Melisi, Davide et al
"LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis." Molecular Cancer Therapeutics
7.4
(2008):
829-840.
Web. 18 Jan. 2021.
